These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38038888)

  • 1. The Renovation of Good Clinical Practice: A Framework for Key Components of ICH E8.
    Whitehead M; Suprin M; Mistree T; Kearns MM; Marini G; Goffe C; Pillwein M; Abdul-Shukkoor V
    Ther Innov Regul Sci; 2024 Mar; 58(2):303-310. PubMed ID: 38038888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survey Results and Recommendations from Japanese Stakeholders for Good Clinical Practice Renovation.
    Nakamura K; Ozawa H; Shibata T; Ushirozawa N; Hata T; Okita N; Fuse N; Sato N; Ikeda K; Hanaoka H; Maruyama T; Wada M; Shimizu S; Kasai H; Yamamoto Y; Sakurai J; Todaka K; Tashiro S; Yamamoto H
    Ther Innov Regul Sci; 2022 Mar; 56(2):220-229. PubMed ID: 34787814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translating a Culture of Quality to Clinical Research Conduct: Expanding the Clinical Development Quality Framework.
    Torok M; Sam L; Hebert J
    Ther Innov Regul Sci; 2024 May; 58(3):404-414. PubMed ID: 38324149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality Tolerance Limits: Framework for Successful Implementation in Clinical Development.
    Bhagat R; Bojarski L; Chevalier S; Görtz DR; Le Meignen S; Makowski M; Nadolny P; Pillwein M; Suprin M; Turri S
    Ther Innov Regul Sci; 2021 Mar; 55(2):251-261. PubMed ID: 32885397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stakeholders' recommendations for revising Good Clinical Practice.
    Corneli A; Forrest A; Swezey T; Lin L; Tenaerts P
    Contemp Clin Trials Commun; 2021 Jun; 22():100776. PubMed ID: 33997463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving the quality conduct and efficiency of clinical trials with training: Recommendations for preparedness and qualification of investigators and delegates.
    Bechtel J; Chuck T; Forrest A; Hildebrand C; Panhuis J; Pattee SR; Comic-Savic S; Swezey T
    Contemp Clin Trials; 2020 Feb; 89():105918. PubMed ID: 31881391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Overview of Current Statistical Methods for Implementing Quality Tolerance Limits.
    Kilaru R; Amodio S; Li Y; Wells C; Love S; Zeng Y; Ye J; Jelizarow M; Balakumar A; Fronc M; Osterdal AS; Rolfe T; Talbot S
    Ther Innov Regul Sci; 2024 Mar; 58(2):273-284. PubMed ID: 38148473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TransCelerate's Clinical Quality Management System: From a Vision to a Conceptual Framework.
    Meeker-O'Connell A; Sam LM; Bergamo N; Little JA
    Ther Innov Regul Sci; 2016 Jul; 50(4):397-413. PubMed ID: 30227025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stakeholders' views on the most and least helpful aspects of the ICH E6 GCP guideline and their aspirations for the revision of ICH E6(R2).
    Dombeck C; Swezey T; Forrest A; Tenaerts P; Corneli A
    Contemp Clin Trials Commun; 2022 Oct; 29():100983. PubMed ID: 36111176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Question-based review for pharmaceutical development: An enhanced quality approach.
    Simões A; Veiga F; Vitorino C
    Eur J Pharm Biopharm; 2024 Feb; 195():114174. PubMed ID: 38160986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Historical Benchmarks for Quality Tolerance Limits Parameters in Clinical Trials.
    Makowski M; Bhagat R; Chevalier S; Gilbert SA; Görtz DR; Kozińska M; Nadolny P; Suprin M; Turri S
    Ther Innov Regul Sci; 2021 Nov; 55(6):1265-1273. PubMed ID: 34453269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The revision of the ICH Good Clinical Practice guidelines: a missed opportunity?
    Ravinetto R
    Indian J Med Ethics; 2017; 2(4):255-259. PubMed ID: 28537222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancing Quality and Efficiency in Clinical Development Through a Clinical QMS Conceptual Framework: Concept Paper Vision and Outline.
    Meeker-O'Connell A; Borda MM; Little JA; Sam LM
    Ther Innov Regul Sci; 2015 Sep; 49(5):615-622. PubMed ID: 30227039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. International Council for Harmonisation E6(R2) addendum: Challenges of implementation.
    Bhatt A
    Perspect Clin Res; 2017; 8(4):162-166. PubMed ID: 29109932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Good intentions and ICH-GCP: Trial conduct training needs to go beyond the ICH-GCP document and include the intention-to-treat principle.
    Browne LH; Graham PH
    Clin Trials; 2014 Dec; 11(6):629-34. PubMed ID: 25023199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Framework for the development and evaluation of complex interventions: gap analysis, workshop and consultation-informed update.
    Skivington K; Matthews L; Simpson SA; Craig P; Baird J; Blazeby JM; Boyd KA; Craig N; French DP; McIntosh E; Petticrew M; Rycroft-Malone J; White M; Moore L
    Health Technol Assess; 2021 Sep; 25(57):1-132. PubMed ID: 34590577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical Analysis of cGMP Large-Scale Expansion Process in Bioreactors of Human Induced Pluripotent Stem Cells in the Framework of Quality by Design.
    Rivera-Ordaz A; Peli V; Manzini P; Barilani M; Lazzari L
    BioDrugs; 2021 Nov; 35(6):693-714. PubMed ID: 34727354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility and acceptability of a structured quality by design approach to enhancing the rigor of clinical studies at an academic health center.
    Moradi H; Schneider M; Streja E; Cooper D
    J Clin Transl Sci; 2021; 5(1):e175. PubMed ID: 34849251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stakeholder perspectives on digital behavioral health applications targeting adolescent depression and suicidality: Policymaker, provider, and community insights.
    Radovic A; Kirk-Johnson A; Coren M; George-Milford B; Kolko D
    Implement Res Pract; 2022; 3():26334895221120796. PubMed ID: 37091099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality by Design in Pharmaceuticals: A Review of its Impact on Regulatory Compliance and Product Quality.
    Nunavath RS; Singh MT; Jain A; Chakma M; Arivuselvam R; Azeeze MSTA
    Drug Res (Stuttg); 2024 Jan; 74(1):18-23. PubMed ID: 38134919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.